Thrombosis Journal

Papers
(The median citation count of Thrombosis Journal is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
An in situ inferior vena cava ligation-stenosis model to study thrombin generation rates with flow44
Risk of recurrent venous thromboembolism and major bleeding according to risk factor profiles in Asian patients: a subgroup analysis EINSTEIN-Extension and EINSTEIN-CHOICE34
Superior sagittal sinus thrombosis in the course of mixed phenotype acute leukaemia treated with acute lymphoblastic leukaemia-like therapy—a case report34
Balancing the risks: continuous vs. interrupted anticoagulation during TAVI – what does the evidence say?31
Effect of different balloon pressure band compression regimens on thrombolysis and lower limb venous blood flow velocity in patients undergoing anterograde thrombolysis via the superficial dorsalis pe29
A snake venom-analog peptide that inhibits SARS-CoV-2 and papain-like protease displays antithrombotic activity in mice arterial thrombosis model, without interfering with bleeding time26
Association of elevated circulating monocyte-platelet aggregates with hypercoagulability in patients with nephrotic syndrome25
Association between red cell distribution width-to-lymphocyte ratio and 30-day mortality in patients with ischemic stroke: a retrospective cohort study24
Application of the Khorana score for cancer-associated thrombosis prediction in patients of East Asian ethnicity undergoing ambulatory chemotherapy21
Factors associated with thrombosis among solid organ cancer patients in Kuala Lumpur, Malaysia20
Effects of combination therapy of antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a systematic review and meta-analysis20
Correction to: The impact on renal function after longterm use of anticoagulants in atrial fibrillation patients19
Comparison between canine and porcine models of chronic deep venous thrombosis19
Monitoring heparin therapy: stability of two different anti-Xa assays using blood samples collected in citrate-containing and CTAD tubes19
The use of infrared thermography for non-invasive detection of bleeding and musculoskeletal abnormalities in patients with hemophilia: an observational study19
Reduced mortality associated with pulmonary embolism response team consultation for intermediate and high-risk pulmonary embolism: a retrospective cohort study18
Vaccine-induced thrombotic thrombocytopenia (VITT): first report from India17
The usefulness of tranexamic acid for bleeding symptoms of chronic consumptive coagulopathy complicated by aortic disease: a single-institute, retrospective study of 14 patients16
Low-density lipoprotein cholesterol-to-lymphocyte count ratio (LLR) is a promising novel predictor of postoperative new-onset deep vein thrombosis following open wedge high tibial osteotomy: a propens16
Direct oral anticoagulants versus low molecular weight heparins for the treatment of cancer-associated thrombosis: a cost-effectiveness analysis16
The effect of recombinant versus plasma-derived von Willebrand factor on prolonged PFA closure times in ECMO patients with acquired von Willebrand syndrome – an observational study15
Lipoxin A4 analogue, BML-111, reduces platelet activation and protects from thrombosis15
Platelet factor 4 polyanion immune complexes: heparin induced thrombocytopenia and vaccine-induced immune thrombotic thrombocytopenia15
The risk factors of liver cirrhosis complicated with portal vein thrombosis and the efficacy and safety of anticoagulant therapy: a meta analysis15
Prognostic significance of stress hyperglycemia ratio in patients with type 2 diabetes mellitus and acute coronary syndromes15
Net reclassification index in comparison of prognostic value of disseminated intravascular coagulation diagnostic criteria by Japanese Society on Thrombosis and Hemostasis and International Society on14
Implementation of early prophylaxis for deep-vein thrombosis in intracerebral hemorrhage patients: an observational study from the Chinese Stroke Center Alliance14
Factors associated with venous thromboembolic disease due to failed thromboprophylaxis13
Treatment of pacemaker-induced superior vena cava syndrome by direct oral anticoagulant13
Safety and efficacy of direct oral anticoagulation in patients with and without radiofrequency ablation of non-valvular atrial fibrillation: a multicenter retrospective cohort study13
Effect of direct oral anticoagulant therapy on pulmonary artery clot dissolution in intermediate high-risk pulmonary thromboembolism13
Sex-specific associations between systolic, diastolic and pulse pressure and hemostatic parameters in the population-based KORA-Fit study: a cross-sectional study12
Efficacy and safety of oral anticoagulants in elderly patients with stable coronary artery disease and atrial fibrillation12
SERPINC1 c.1247dupC: a novel SERPINC1 gene mutation associated with familial thrombosis results in a secretion defect and quantitative antithrombin deficiency12
Postoperative intermittent pneumatic compression for preventing venous thromboembolism in Chinese lung cancer patients: a randomized clinical trial12
Structure, signal transduction, activation, and inhibition of integrin αIIbβ312
A single-center study of reference intervals for TAT, PIC, TM and t-PAIC in healthy older Chinese adults12
Exploring the genetic basis between inflammatory bowel disease and venous thromboembolism11
Aspirin and clopidogrel resistance; a neglected gap in stroke and cardiovascular practice in Iran: a systematic review and meta-analysis11
Correlation between a 2-week change in platelet count and clinical outcomes after the initiation of ravulizumab treatment in adult patients with atypical hemolytic uremic syndrome: post-hoc analysis o11
Association between obstructive sleep apnea and venous thromboembolism recurrence: results from a French cohort11
Clopidogrel vs. ticagrelor in ST-elevation myocardial infarction complicated by cardiogenic shock undergoing primary PCI11
Gender-specific relationships between hyperuricemia and idiopathic deep venous thrombosis in the Chinese population: a case‒control study11
Spontaneous rectus sheath hematoma associated with apixaban in an elderly gentleman with chronic obstructive airway disease – a case report11
Clot time ratio (CTR) and relation to treatment outcome in patients with atrial fibrillation treated with Rivaroxaban10
Association of inherited thrombophilia mutations and their combinations among palestinian women with unexplained recurrent miscarriage10
Endovascular revascularization strategies using catheter-based thrombectomy versus conventional catheter-directed thrombolysis for acute limb ischemia10
A case report of spontaneous pectoral hematoma in a male with background antiplatelet therapy after severe COVID-19 infection10
Clinical trial assessing the safety of edoxaban with concomitant chemotherapy in patients with gynecological cancer-associated thrombosis (EGCAT study)10
Agitation-dependent biomechanical forces modulate GPVI receptor expression and platelet adhesion capacity during storage10
Identification of key risk factors for venous thromboembolism in urological inpatients based on the Caprini scale and interpretable machine learning methods10
The efficacy and safety of direct oral anticoagulants compared with vitamin K antagonist in patients with hypertrophic cardiomyopathy and atrial fibrillation10
Antithrombotic therapy at discharge and prognosis in patients with chronic coronary syndrome and atrial fibrillation who underwent PCI: a real-world study10
Correction: Outcomes of deep venous thrombosis management and associated factors among patients in tertiary hospitals in Addis Ababa, Ethiopia: a multicenter retrospective cohort study9
Effect of heparin treatment on pulmonary embolism and in-hospital death in unvaccinated COVID-19 patients without overt deep vein thrombosis9
Education and clinical pharmacist-led management strategies for the risk and prophylaxis of venous thromboembolism in general surgery9
Practical approach to thrombocytopenia in patients with sepsis: a narrative review9
Anticoagulation control, outcomes, and associated factors in long-term-care patients receiving warfarin in Africa: a systematic review9
Replacement of traditional prothrombin time monitoring with the new Fiix prothrombin time increases the efficacy of warfarin without increasing bleeding. A review article9
NETosis and SARS-COV-2 infection related thrombosis: a narrative review9
Causal inference of sex hormone-binding globulin on venous thromboembolism: evidence from Mendelian randomisation9
Heparin-free after 3000 IU heparin loaded in veno-venous ECMO supported acute respiratory failure patients with hemorrhage risk: a novel anti-coagulation strategy9
Comparison of the efficacy and safety of rivaroxaban and low-molecular-weight heparin in Chinese lung cancer patients with nonhigh-risk pulmonary embolism9
Enoxaparin dosing for venous thromboembolism prophylaxis in hospitalized underweight adult patients: a retrospective cohort study9
Standard- versus intermediate-dose enoxaparin for anti-factor Xa guided thromboprophylaxis in critically ill patients with COVID-198
Catheter-directed therapy for pulmonary embolism in pediatrics: a systematic review and meta-analysis8
Deep vein thrombosis in Ethiopia: a systematic review and meta-analysis, 20258
A case-control study on factor V Leiden: an independent, gender-dependent risk factor for venous thromboembolism8
Assessing outcomes after thrombectomy with or without iliac vein stenting for young provoked DVT patients with iliac vein stenosis8
Lupus anticoagulant associated with low grade B-cell lymphoma and IgM paraproteinaemia with lupus cofactor phenomenon on DRVVT and SCT assays - a possible novel association8
Safety and efficacy of direct oral anticoagulants in stroke prevention in patients with atrial fibrillation complicated with anemia and/or thrombocytopenia: a retrospective cohort study8
Morphologic change in deep venous thrombosis in the lower extremity after therapeutic anticoagulation8
Causes of death after first time venous thromboembolism8
A case of acquired thrombotic thrombocytopenic purpura induced by acute severe hepatitis E: successfully treated by plasma exchange and rituximab8
A study of recurrent life-threatening thrombosis accompanied with the duplication of the factor IX gene8
Comparison of VTE risk scores in guidelines for VTE diagnosis in nonsurgical hospitalized patients with suspected VTE8
Enhanced in vivo and ex vivo thrombin generation after lower-leg trauma, but not after knee arthroscopy8
Incidence of anti-platelet factor4/polyanionic antibodies, thrombocytopenia, and thrombosis after COVID-19 vaccination with ChAdOx1 nCoV-19 in Thais7
Predictors of pulmonary embolism in hospitalized patients with COVID-197
Adrenal hemorrhage following direct oral anticoagulant (DOAC) therapy: two case reports and literature review7
Coagulation biomarkers and coronavirus disease 2019 phenotyping: a prospective cohort study7
Coagulation dysfunction events associated with echinocandins: a real-world study from FDA adverse event reporting system (FAERS) database7
A primary pulmonary artery sarcoma masquerading pulmonary embolism: a case report and literature review7
Prediction of residual ischemic risk in ticagrelor-treated patients with acute coronary syndrome7
Venous thromboembolic disease in admitted blunt trauma patients: what matters?7
Insulin resistance, metabolic syndrome and micro-RNA-122 serum level in patients with cerebral venous sinus thrombosis: a case-control study7
Prevalence of venous thromboembolism and evaluation of a modified caprini risk assessment model: a single-centre, prospective cohort study involving patients undergoing lung resections for bronchiecta7
Laboratory evaluation of a new integrative assay to phenotype plasma fibrinolytic system7
Incidence and risk factors of venous thrombotic events in patients with interstitial lung disease during hospitalization7
Pulmonary embolism in a patient with eltrombopag-treated aplastic anaemia and paroxysmal nocturnal haemoglobinuria clone during COVID-19 pneumonia7
Long noncoding RNA TUG1 induces angiogenesis of endothelial progenitor cells and dissolution of deep vein thrombosis7
Escalating doses of intravenous APAC demonstrate antithrombotic effect in pigs7
“Y appearance” infarction: caused by essential thrombocythemia6
Lemierre’s syndrome complicating deep neck abscess: a case report6
The evolution of clot strength in critically-ill COVID-19 patients: a prospective observational thromboelastography study6
Impact of baseline renal function on the efficacy and safety of different Anticoagulants in Atrial Fibrillation Patients – A cohort study6
Anticoagulation strategy and safety in critically ill COVID-19 patients: a French retrospective multicentre study6
A retrospective multicenter cohort study of the association between anti-Factor Xa values and death, thromboembolism, and bleeding in patients with critical COVID-196
The effect of neutrophil extracellular traps in venous thrombosis6
Use of thromboelastography before the administration of hemostatic agents to safely taper recombinant activated factor VII in acquired hemophilia A: a report of three cases6
Parapneumonic effusion is a risk factor for VTE in hospitalized patients with community-acquired pneumonia: a retrospective cohort study6
The effect of Mycobacterium tuberculosis treatment on thrombelastography-assessed haemostasis: a prospective cohort study6
Frequency of deep vein thrombosis at admission for acute stroke and associated factors: a cross-sectional study6
The clinical application of venous ultrasound in diagnosis and follow-up of lower extremity deep vein thrombosis (DVT): a case-based discussion6
Chronic anti-coagulation therapy reduced mortality in patients with high cardiovascular risk early in COVID-19 pandemic6
Synergistic effects of rivaroxaban and hypothermia or acidosis on coagulation initiation measured with ROTEM®: a prospective observational study6
Causal relationship between varicose veins and mean corpuscular hemoglobin concentration based on Mendelian randomization study6
LMWHs dosage and outcomes in acute pulmonary embolism with renal insufficiency, an analysis from a large real-world study6
National trends in venous thromboembolism-related mortality among pancreatic cancer patients in the United States, 1999–20205
Management of edoxaban therapy and clinical outcomes in patients undergoing major or nonmajor surgery: a subanalysis of the EMIT-AF/VTE study5
Evaluation of prothrombotic risk of two PROC hotspot mutations (Arg189Trp and Lys193del) in Chinese population: a retrospective study5
Modified thromboelastometric tests provide improved sensitivity and specificity to direct oral anticoagulants compared to standard thromboelastometric tests in-vitro5
Early identification of lung cancer patients with venous thromboembolism: development and validation of a risk prediction model5
Causal association between circulating blood cell traits and pulmonary embolism: a mendelian randomization study5
The prevalence and risk factors of pulmonary embolism in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis5
miR-1915-3p regulates megakaryocytic and erythroid differentiation by targeting SOCS45
Cortical vein involvement and its influence in a cohort of adolescents with cerebral venous thrombosis5
Association between cancer history and second-generation drug-eluting stent thrombosis: insights from the REAL-ST registry5
Time series differences in coagulopathy in mechanically ventilated COVID-19 and bacterial pneumonia patients: a nationwide observational study in Japan5
Right heart thrombus in transit and peripherally inserted central catheters5
Testing P2Y12 platelet inhibitors generics beyond bioequivalence: a parallel single-blinded randomized trial5
Pregnancy and thrombosis risk for women without a history of thrombotic events: a retrospective study of the real risks5
Monitoring the efficiency of reversal on anti-Xa direct oral anticoagulants using point-of-care viscoelastic testing5
External validation and update of the International Medical Prevention Registry on Venous Thromboembolism bleeding risk score for predicting bleeding in acutely ill hospitalized medical patients: a re5
Clinical characteristics of COVID-19 associated vasculopathic diseases5
Under the dual effect of inflammation and pulmonary fibrosis, CTD-ILD patients possess a greater susceptibility to VTE5
Preventive strategies for hypercoagulation in Cushing’s syndrome: when and how5
Risk factors for deep venous thrombosis following total hip arthroplasty: a meta-analysis5
Development and validation of a new risk assessment model for immunomodulatory drug-associated venous thrombosis among Chinese patients with multiple myeloma5
Coagulation dysfunction events associated with tigecycline: a real-world study from FDA adverse event reporting system (FAERS) database5
A 11-year-old boy with Blastocystis hominis infection, presents as immune thrombocytopenia5
Single-leaflet reconstruction surgery for severe chronic lower limb venous insufficiency caused by post-thrombotic syndrome: a case report and literature review5
A nomogram model for predicting preoperative DVT in elderly anemic patients undergoing total hip arthroplasty: a retrospective cohort study5
Risk factors for thrombolysis-related intracranial hemorrhage: a systematic review and meta-analysis5
Reply to correspondence: Cancer incidence and mortality after a first-ever venous thrombosis in northern Sweden5
Laboratory and clinical haemostatic aberrations in primary dermatologic disease: A review4
Inflammatory biomarkers may be associated with poor outcomes after mechanical thrombectomy4
Progress in the clinical effects and adverse reactions of ticagrelor4
Outcomes of deep venous thrombosis management and associated factors among patients in tertiary hospitals in Addis Ababa, Ethiopia: a multicenter retrospective cohort study4
Long-term efficacy and safety of anticoagulant for cavernous transformation of the portal vein cirrhotic patient with extrahepatic portal vein obstruction4
Anlotinib dramatically improved pulmonary hypertension and hypoxia caused by Pulmonary Tumor Thrombotic Microangiopathy (PTTM) associated with gastric carcinoma: a case report4
Identification of two point mutations associated with inherited antithrombin deficiency4
Direct oral anticoagulants versus warfarin for venous thromboembolism prophylaxis in nephrotic syndrome patients: a retrospective study4
Establishment and validation of a predictive model for lower extremity deep vein thrombosis in patients with traumatic pelvic fractures4
Use of laboratory testing for prediction of postoperative bleeding volume in cardiovascular surgery4
Robust preimplantation genetic testing of the common F8 Inv22 pathogenic variant of severe hemophilia A using a highly polymorphic multi-marker panel encompassing the paracentric inversion4
Successful venous thromboprophylaxis in a patient with vaccine-induced immune thrombotic thrombocytopenia (VITT): a case report of the first reported case in Thailand4
D-dimer to fibrinogen ratio as a marker for acute cerebral venous thrombosis4
Standard dosing of enoxaparin versus unfractionated heparin in critically ill patient with COVID-19: a multicenter propensity-score matched study4
Genetically predicted the causal association between serum mineral elements with immune thrombocytopenia and Henoch-Schonlein purpura: a bidirectional two-sample Mendelian randomization analysis4
Extended use of dual antiplatelet therapy among older adults with acute coronary syndromes and associated variables: a cohort study4
Evaluation of Apixaban standard dosing in underweight patients with non-valvular atrial fibrillation: a retrospective cohort study4
An evaluation of circulating activated TAFI in septic DIC: a case series and review of the literature4
Prognosis of incidental pulmonary embolism vs. symptomatic pulmonary embolism in cancer patients: a single-center retrospective cohort study in China4
Systematic review and meta-analysis of association between plasminogen activator inhibitor-1 4G/5G polymorphism and recurrent pregnancy loss: an update4
Modern thromboprophylaxis protocol based on guidelines applied in a respiratory intensive care unit: a single-center prospective cohort study4
Association of initial national early warning score with clinical deterioration in pulmonary embolism4
Tranexamic acid for haemostasis and beyond: does dose matter?4
Prevalence and risk factors of preoperative venous thromboembolism in patients with malignant musculoskeletal tumors: an analysis based on D-dimer screening and imaging4
Narsoplimab for severe transplant-associated thrombotic microangiopathy4
The association between ROS1 rearrangement and risk of thromboembolic events in patients with advanced non-small cell lung cancer: a multicenter study in China4
Extracellular PDI in thrombosis and vascular injury4
Immune activation and inflammatory biomarkers as predictors of venous thromboembolism in lymphoma patients4
Patient self-management of warfarin therapy – a long-term follow up study4
The potential impact of Covid-19 on the capacity of routine laboratory tests to detect heparin-induced thrombocytopenia4
Clinical impact of the PAI-1 4G/5G polymorphism in Chinese patients with venous thromboembolism4
Correction: Prognostic value of plasma high mobility group box 1 protein and histone H3 levels in patients with disseminated intravascular coagulation: a multicenter prospective cohort study4
Neutrophil levels upon admission for the assessment of acute pulmonary embolism with intermediate- and high-risk: an indicator of thrombosis and inflammation4
Immune thrombotic thrombocytopenic purpura and diabetic ketoacidosis: a case report and literature review4
Multiple venous thromboembolisms in a pregnant patient carrying a novel mutation in SERPINC1 (p.M313T) that causes a transient antithrombin deficiency: a case report4
Malignant tumor is the greatest risk factor for pulmonary embolism in hospitalized patients: a single-center study4
Letter to editor: Impact of extracorporeal membrane oxygenation treatments on acquired von willebrand syndrome in patients with out of-hospital cardiac arrest: a retrospective observational study4
Simplified predictive scores for thrombosis and bleeding complications in newly diagnosed acute leukemia patients3
Haemostasis patterns in patients with acute-on-chronic liver failure and acute decompensation of cirrhosis including thromboelastometric tests with and without the addition of Protac: a pilot study3
Low risk of haematomas with intramuscular vaccines in anticoagulated patients: a systematic review with meta-analysis3
A prediction model for left ventricular thrombus persistence/recurrence: based on a prospective study and a retrospective study3
Heparin-induced thrombocytopenia in extracorporeal membrane oxygenation-supported patients: a systematic review and meta-analysis3
Utilization of the Caprini risk assessment model(RAM) to predict venous thromboembolism after primary hip and knee arthroplasty: an analysis of the Healthcare Cost and Utilization Project(HCUP)3
A mendelian randomization study on the association between 731 types of immune cells and 91 types of blood cells with venous thromboembolism3
Real-world practices of low-molecular-weight heparin for venous thromboembolism prophylaxis in patients hospitalized with COVID-19: a multicenter prospective study from China3
Bleeding risks with novel oral anticoagulants especially rivaroxaban versus aspirin: a meta-analysis3
Clinical characteristics of venous thromboembolism onset from severe high altitude pulmonary edema in plateau regions3
Anticoagulant effects of edoxaban in cancer and noncancer patients with venous thromboembolism3
Renal damage and old age: risk factors for thrombosis in patients with ANCA-associated vasculitis3
Acute lower limb ischemia caused by vaccine-induced immune thrombotic thrombocytopenia: focus on perioperative considerations for 2 cases3
Thromboembolic and hemorrhagic risks after vaccination against SARS-CoV-2: a systematic review and meta-analysis of randomized controlled trials3
Two cases of venous thromboembolism in siblings after splenectomy due to a novel PROC gene mutation3
Relationship between serum uric acid levels and pulmonary embolism: an age-based stratified analysis3
Cerebral venous sinus thrombosis associated with SRA-negative heparin-induced thrombocytopenia: case report3
Relationships between coagulation factors and thrombin generation in a general population with arterial and venous disease background3
Potential value of the calibrated automated thrombogram in patients after a cerebral venous sinus thrombosis; an exploratory study3
Optimal authoritative risk assessment score of Cancer-associated venous thromboembolism for hospitalized medical patients with lung Cancer3
Differences between surviving and non-surviving venous thromboembolism COVID-19 patients: a systematic review3
Restenosis after excimer laser coronary atherectomy and drug-coated balloon dilation in Takayasu’s arteritis: a case report and review of the literature3
Predictive ability of viscoelastic testing using ClotPro® for short-term outcome in patients with severe Covid-19 ARDS with or without ECMO therapy: a retrospective study3
Von Willebrand disease (VWD) and pregnancy: a comprehensive overview3
The efficacy of tranexamic acid treatment with different time and doses for traumatic brain injury: a systematic review and meta-analysis3
The relationship between self-efficacy and treatment satisfaction among patients with anticoagulant therapy: a cross-sectional study from a developing country3
The role of controlling nutritional status score in predicting postthrombotic syndrome in patients with lower extremity deep venous thrombosis2
Hyper-responsiveness to warfarin in a young patient with the VKORC1 -1639GA/CYP2C9*1*46 genotype: a case report2
Coexistence of antithrombin deficiency and suspected inferior vena cava atresia in an adolescent and his mother – case report and clinical implications2
Hospitalized patients with isolated distal deep vein thrombosis: anticoagulation therapy or not?2
Antiphospholipid antibodies are associated with increased levels of selected oxidative stress biomarkers2
Efficacy and safety of anticoagulant for treatment and prophylaxis of VTE patients with renal insufficiency: a systemic review and meta-analysis2
Arterial thrombosis triggered by methotrexate-induced hyperhomocysteinemia in a systemic lupus erythematosus patient with antiphospholipid antibodies2
Deep vein thrombosis in severe community-acquired pneumonia patients undergoing thromboprophylaxis: Prevalence, risk factors, and outcome2
Intracoronary versus intravenous glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention in patients with STEMI: a systematic review and meta-analysis2
Risk factors for central venous catheter-associated deep venous thrombosis in pediatric critical care settings identified by fusion model2
Comparative effectiveness and safety of DOACs vs. VKAs in treatment of left ventricular thrombus- a meta-analysis update2
Antibiotic use in acute mesenteric ischemia: a review of the evidence and call to action2
Superior vena cava syndrome after pacemaker implantation treated with direct oral anticoagulation2
Factors influencing DVT formation in sepsis2
Association between liver fibrosis and thrombotic or bleeding events in acute coronary syndrome patients2
Role of ticagrelor in the peri-thrombolytic phase for patients with ST-segment elevation myocardial infarction: a comprehensive review2
Heparin therapy in sepsis and sepsis-associated disseminated intravascular coagulation: a systematic review and meta-analysis2
The effectiveness of atorvastatin for the prevention of deep vein thrombosis in cancer patients undergoing chemotherapy2
Anticoagulation control for nonvalvular atrial fibrillation in a tertiary academic centre in Johannesburg2
D-dimer and fibrinogen indicate ischemic risk in patients with atrial fibrillation after percutaneous coronary intervention2
Predictive value of magnetic resonance angiography combined with serum ischemia-modified albumin for secondary cerebral infarction after transient ischemic attack2
Successful retrieval of tip-embedded inferior vena cava filter using a modified forceps technique: case report2
Cancer-associated venous thromboembolism: a comprehensive review2
Endoplasmic reticulum protein 29 negatively regulates platelet functions and thrombosis in mice2
Risk of thrombotic events in immune thrombocytopenia patients treated with thrombopoietic agents: a systematic review and meta-analysis2
Intermediate-to-therapeutic versus prophylactic anticoagulation for coagulopathy in hospitalized COVID-19 patients: a systemic review and meta-analysis2
Interventional therapy for a case of Mycoplasma pneumoniae pneumonia complicated by upper extremity arterial embolism in a child: a case report2
Echogenicity of carotid plaques as a predictor of regression following lipid-lowering therapy2
Asymptomatic and symptomatic deep venous thrombosis in hospitalized acutely ill medical patients: risk factors and therapeutic implications2
The use of direct oral anticoagulants for thromboprophylaxis or treatment of cancer-associated venous thromboembolism: a meta-analysis and review of the guidelines2
Long non-coding RNA crnde promotes deep vein thrombosis by sequestering miR-181a-5p away from thrombogenic Pcyox1l2
Eno1 in sepsis-induced coagulopathy: a pleiotropic mechanism hypothesis involving immunomodulation and endothelial dysfunction2
Clinical outcomes in patients receiving edoxaban or phenprocoumon for prevention of stroke in atrial fibrillation: a German real-world cohort study2
Spontaneous coronary artery dissection in a young patient with antiphospholipid syndrome2
Risk factors for venous thromboembolism in a single pediatric intensive care unit in China2
A prediction nomogram for deep venous thrombosis risk in patients undergoing primary total hip and knee arthroplasty: a retrospective study2
A novel prognostic prediction indicator in patients with acute pulmonary embolism: Naples prognostic score2
Recurrence in isolated distal DVT after anticoagulation: a systematic review and meta-analysis of axial and muscular venous thrombosis2
Impact of extracorporeal membrane oxygenation treatments on acquired von Willebrand syndrome in patients with out-of-hospital cardiac arrest: a retrospective observational study2
High incidence of undiagnosed deep vein thrombosis among hospitalized people living with HIV: a cross-sectional study2
Characterization of spreading depolarizations in swine following superior sagittal sinus occlusion: a novel gyrencephalic model study2
0.13298916816711